Yonyou Network Technology (600588) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
25 Apr, 2026Executive summary
Achieved revenue of RMB 1.46 billion in Q1 2026, up 5.9% year-over-year; cloud services revenue grew 8.1% and core BIP product revenue rose 26.8%.
Net loss attributable to shareholders was RMB 722.6 million, a reduction of RMB 13.2 million year-over-year; gross margin improved by 5.7 percentage points to 44.7%.
AI business generated RMB 137.4 million in revenue, with significant product launches and major enterprise contracts signed.
Employee count reduced by 1,308 to 17,747 by end of Q1 2026, reflecting organizational optimization.
Financial highlights
Operating income: RMB 1,459 million, up 5.9% year-over-year.
Net loss attributable to shareholders: RMB -722.6 million, improved from RMB -735.8 million year-over-year.
Basic and diluted EPS: -0.22, unchanged year-over-year.
Operating cash flow: RMB -1,005 million, slightly improved from RMB -1,022 million year-over-year.
Total assets: RMB 21.13 billion, down 2.31% from year-end 2025.
Outlook and guidance
Continued focus on AI-driven product innovation, global market expansion, and cloud services growth.
Ongoing organizational optimization and talent acquisition in AI.
Latest events from Yonyou Network Technology
- Net loss narrowed on stable revenue, improved margins, and strong cloud/AI growth.600588
Q4 202517 Apr 2026 - Revenue up, losses narrowed, and cloud/AI/overseas growth accelerated in Q3.600588
Q3 202531 Oct 2025 - Revenue fell 21.2% and net loss widened as the subscription transition accelerated.600588
Q1 202510 Sep 2025 - Revenue fell 5.9% but cloud and AI contracts surged, setting up for a stronger H2.600588
Q2 202527 Aug 2025 - Revenue growth slowed and losses widened, but cloud and subscription segments outperformed.600588
Q3 202413 Jun 2025 - Cloud-driven revenue growth and margin improvement, with net loss narrowing in H1 2024.600588
Q2 202413 Jun 2025 - Net loss widened to RMB 2.06 billion as revenue fell and R&D, impairment costs rose.600588
Q4 20249 Jun 2025